Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
B.G. Kim
Observed names:
B.-G. Kim,
Bang Ju Kim,
Bangju Kim,
Byung‐Ik Kim
Institutions:
Myongji Hospital,
Jecheon Myongji Hospital
Observed institutions:
Samsung Medical Center,
Kangbuk Samsung Hospital,
Myongji Hospital,
Jecheon Myongji Hospital,
Dong-A University,
Sungkyunkwan University
show all 6
ORCID:
0009-0008-2692-8903
Observed ORCID:
0009-0008-2692-8903
OpenAlex ID:
A5058284281
Twenty‐four‐week clevudine therapy showed potent and sustained antiviral activity in HBeAg‐positive chronic hepatitis B†‡
2007
·
Byung Chul Yoo
, Ju Hyun Kim
, et al.
·
Hepatology
·
135
PDF
A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer (Gynecologic Oncology Group 0213)
2015
·
R.L. Coleman
, M.F. Brady
, et al.
·
Gynecologic Oncology
·
44
Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases
2014
·
A. Yoon
, D.S. Bae
, et al.
·
Gynecologic Oncology
·
4
ENGOT-ov43/keylynk-001: A phase III, placebo- and active-controlled trial of pembrolizumab plus chemotherapy with olaparib maintenance for first-line treatment of advanced BRCA-nonmutated epithelial ovarian cancer
2020
·
R.L. Coleman
, K. Fujiwara
, et al.
·
Gynecologic Oncology
·
3
Impact of interval from definitive surgery to initiation of adjuvant chemotherapy (ISC) on survival in advanced epithelial ovarian cancer
2016
·
E.J. Heo
, E.S. Paik
, et al.
·
Gynecologic Oncology
·
2
PDF
The effects of itraconazole as anti-cancer agent in epithelial ovarian cancer
2015
·
J.W. Lee
, Y.Y. Lee
, et al.
·
Gynecologic Oncology
·
2
Brain hemorrhage in patients with advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
2025
·
Bangju Kim
, Hyun Joon Park
, et al.
·
Kosin Medical Journal
·
1
Development and validation of chemoradio-prediction model using reverse-phase protein arrays in locally advanced cervical cancer
2016
·
C.H. Choi
, J.Y. Chung
, et al.
·
Gynecologic Oncology
·
1
PDF
Therapeutic targeting of c-Met in ovarian clear cell carcinoma
2015
·
A. Yoon
, J.W. Lee
, et al.
·
Gynecologic Oncology
·
1
Gastric cancer with lymphoid stroma mimicking a subepithelial lesion after a 10-year disease-free interval: a case report
2025
·
Bang Ju Kim
, Sung Eun Kim
, et al.
·
Kosin Medical Journal
P17-02 Study of forensic research via omics markers in environmental health vulnerable area
2024
·
Y.S. Hong
, J.Y. Kwon
, et al.
·
Toxicology Letters
Stability and preclinical efficacy of patient-derived xenograft (PDX) models in endometrial cancer and uterine sarcoma
2020
·
S.Y. Jeong
, J.H. Kang
, et al.
·
Gynecologic Oncology
The effect of time to chemotherapy interval on low-grade serous ovarian cancer in aspect of progression free survival and overall survival
2020
·
J.H. Kang
, C.H. Choi
, et al.
·
Gynecologic Oncology
An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: A Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION
2019
·
J.-Y. Lee
, J.W. Kim
, et al.
·
Annals of Oncology
Old age as a poor prognostic factor in epithelial ovarian cancer: What is the best age cutoff?
2019
·
W.Y. Kim
, J. Kim
, et al.
·
Gynecologic Oncology
CDK7 as a potential therapeutic target for ovarian cancer: Preclinical study
2019
·
W.Y. Kim
, J. Kim
, et al.
·
Gynecologic Oncology
Anti-cancer effect of PARP inhibitor (olaparib) with DNA-demethylating agent (5-Azacytidine) in ovarian cancer
2019
·
S.Y. Jeong
, M.S. Kim
, et al.
·
Gynecologic Oncology
The prognosis of epithelial ovarian cancer patients who are refractory after neoadjuvant chemotherapy
2019
·
W. Shin
, J. Noh
, et al.
·
Gynecologic Oncology
Bevacizumab plus chemotherapy versus combination chemotherapy only in metastatic, recurrent, and persistent cervical cancer
2019
·
H. Choi
, B.G. Kim
, et al.
·
Gynecologic Oncology
Anti-tumor effects of tetraarsenic oxide (TAO, As4O6) in human cervical cancer
2019
·
M.S. Kim
, S.Y. Jeong
, et al.
·
Gynecologic Oncology
Optimal Treatment Duration and Change in Anti-Aspergillus IgG Serum Levels in Chronic Pulmonary Aspergillosis
2019
·
Y. Im
, B.W. Jhun
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Prognostic model for disease-free survival, lymphatic and/or hematogenous recurrence, in patients with early stage cervical cancer treated with radical hysterectomy: A Korean Gynecologic Oncology Group study
2018
·
E.S. Paik
, J.H. Kim
, et al.
·
Gynecologic Oncology
Single nucleotide polymorphism and associated gene expression related with Japanese ovarian clear cell adenocarcinoma: eQTL analysis using HapMap3 and survival analysis with TCGA data
2018
·
J.H. Kim
, E.S. Paik
, et al.
·
Gynecologic Oncology
Preclinical trial of targeted agents using NGS, HTS and PDX models in gynecologic cancer
2018
·
J.H. Kim
, H.J. Choi
, et al.
·
Gynecologic Oncology
Survival impact of quality of lymphadenectomy in intermediate- or high-risk group of endometrioid type endometrial cancer: A multicenter retrospective cohort analysis
2016
·
T.H. Kim
, T.J. Kim
, et al.
·
Gynecologic Oncology
PDF
Show more works
View as search
Works count:
37
Citation count:
193
H-index:
3
I10-index:
2
Year
Topic
Type
